» Articles » PMID: 35973994

Loss of FOXA2 Induces ER Stress and Hepatic Steatosis and Alters Developmental Gene Expression in Human IPSC-derived Hepatocytes

Overview
Journal Cell Death Dis
Date 2022 Aug 16
PMID 35973994
Authors
Affiliations
Soon will be listed here.
Abstract

FOXA2 has been known to play important roles in liver functions in rodents. However, its role in human hepatocytes is not fully understood. Recently, we generated FOXA2 mutant induced pluripotent stem cell (FOXA2iPSC) lines and illustrated that loss of FOXA2 results in developmental defects in pancreatic islet cells. Here, we used FOXA2iPSC lines to understand the role of FOXA2 on the development and function of human hepatocytes. Lack of FOXA2 resulted in significant alterations in the expression of key developmental and functional genes in hepatic progenitors (HP) and mature hepatocytes (MH) as well as an increase in the expression of ER stress markers. Functional assays demonstrated an increase in lipid accumulation, bile acid synthesis and glycerol production, while a decrease in glucose uptake, glycogen storage, and Albumin secretion. RNA-sequencing analysis further validated the findings by showing a significant increase in genes associated with lipid metabolism, bile acid secretion, and suggested the activation of hepatic stellate cells and hepatic fibrosis in MH lacking FOXA2. Overexpression of FOXA2 reversed the defective phenotypes and improved hepatocyte functionality in iPSC-derived hepatic cells lacking FOXA2. These results highlight a potential role of FOXA2 in regulating human hepatic development and function and provide a human hepatocyte model, which can be used to identify novel therapeutic targets for FOXA2-associated liver disorders.

Citing Articles

Role of HNF6 in liver homeostasis and pathophysiology.

Tian M, Gao W, Ma S, Cao H, Zhang Y, An F Mol Med. 2025; 31(1):48.

PMID: 39910442 PMC: 11800625. DOI: 10.1186/s10020-025-01105-9.


ER stress-induced YAP upregulation leads to chondrocyte phenotype loss in age-related osteoarthritis.

Gao Y, Wei H, Peng X, Wang C, Zhu H, Yin J Front Pharmacol. 2024; 15:1476255.

PMID: 39600372 PMC: 11588467. DOI: 10.3389/fphar.2024.1476255.


Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1/NKX6.1 progenitors.

Aldous N, Elsayed A, Memon B, Ijaz S, Hayat S, Abdelalim E Diabetologia. 2024; 67(12):2786-2803.

PMID: 39080045 PMC: 11604831. DOI: 10.1007/s00125-024-06232-2.


Identifying miRNA Signatures Associated with Pancreatic Islet Dysfunction in a FOXA2-Deficient iPSC Model.

Elsayed A, Aldous N, Alajez N, Abdelalim E Stem Cell Rev Rep. 2024; 20(7):1915-1931.

PMID: 38916841 PMC: 11445299. DOI: 10.1007/s12015-024-10752-0.


FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.

Liu N, Wang A, Xue M, Zhu X, Liu Y, Chen M Cell Death Discov. 2024; 10(1):172.

PMID: 38605023 PMC: 11009302. DOI: 10.1038/s41420-024-01936-1.


References
1.
Petersen M, Shulman G . Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018; 98(4):2133-2223. PMC: 6170977. DOI: 10.1152/physrev.00063.2017. View

2.
Wang P, Cong M, Liu T, Li Y, Liu L, Sun S . FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis. J Cell Physiol. 2020; 235(12):9524-9537. DOI: 10.1002/jcp.29759. View

3.
Crowe A, Sang L, Li K, Lee K, Spear B, Barton M . Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the alpha-fetoprotein gene. J Biol Chem. 1999; 274(35):25113-20. DOI: 10.1074/jbc.274.35.25113. View

4.
Wang W, Yao L, Shen W, Ding K, Shi P, Chen F . FOXA2 alleviates CCl-induced liver fibrosis by protecting hepatocytes in mice. Sci Rep. 2017; 7(1):15532. PMC: 5686201. DOI: 10.1038/s41598-017-15831-6. View

5.
Jeong Y, Epstein D . Distinct regulators of Shh transcription in the floor plate and notochord indicate separate origins for these tissues in the mouse node. Development. 2003; 130(16):3891-902. DOI: 10.1242/dev.00590. View